Notice of Closed Meeting, 71867-71868 [2023-23007]

Download as PDF 71867 Federal Register / Vol. 88, No. 200 / Wednesday, October 18, 2023 / Notices CRITERIA FOR INCLUSION/EXCLUSION OF STUDIES IN THE REVIEW Domain Inclusion Exclusion Population .................. • Publications that address quality of care indicators, criteria, or benchmarks. We will accept the authors’ definition of quality of care. Quality indicators may include care processes-related measures (e.g., follow-up post discharge, continuity of care, medication errors), heath services utilization measures (e.g., hospital readmission, emergency department visit), care satisfaction (e.g., patient satisfaction, care needs met, trust in care provider), or health outcomes (e.g., mortality, physical functional status, mental functioning, quality of life) used as quality indicators. Publications that do not address quality of care in detail but include quality of care and health equity in a framework will also be eligible. Care disparities may either address differences in provided health services, focus on care services or health outcomes of priority populations. • Publications that include a figure or detailed description of a framework of quality of care or care disparities; frameworks may use the format of a logic model, analytic framework, conceptual model, or other conceptualizations of quality of care. • Publications not addressing quality of care and publications not mentioning quality of care nor health equity as a central feature of a framework. Concept ..................... Context ...................... • Healthcare, specifically healthcare delivery organizations .......................................... Other limiters ............. • Reports published in English-language, journal manuscripts, trial records, and gray literature in the public domain from the outlined sources. Dated: October 12, 2023. Marquita Cullom, Associate Director. [FR Doc. 2023–22915 Filed 10–17–23; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention ddrumheller on DSK120RN23PROD with NOTICES1 Notice of Closed Meeting Pursuant to section 5 U.S.C. Section1009(d), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)CE24–013, Research Grants to Identify VerDate Sep<11>2014 18:01 Oct 17, 2023 Jkt 262001 Effective Community-Based Strategies for Overdose Prevention (R01). Date: March 12–13, 2024. Time: 8:30 a.m.–5 p.m., EDT. Place: Web Conference. Agenda: To review and evaluate grant applications. For Further Information Contact: Aisha L. Wilkes, M.P.H., Scientific Review Officer, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, 4770 Buford Highway NE, Mailstop S106–9, Atlanta, Georgia 30341, Telephone: (404)639–6473; Email: AWilkes@cdc.gov. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2023–23006 Filed 10–17–23; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 • Publications citing existing frameworks without further conceptual contribution to the framework and publications describing only the need of quality of care measures. • Studies in contexts outside of healthcare or not specific to healthcare. • Data reported in abbreviated format (e.g., conference abstracts) will be excluded; studies not published in English • Systematic reviews will be retained for reference mining. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Closed Meeting Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended, and the Determination of the Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)— CE24–029, Grants to Support New Investigators in Conducting Research Related to Preventing Interpersonal Violence Impacting Children and Youth. Date: March 19, 2024. Time: 8:30 a.m.–5 p.m., EDT. Place: Web Conference. Agenda: To review and evaluate grant applications. E:\FR\FM\18OCN1.SGM 18OCN1 71868 Federal Register / Vol. 88, No. 200 / Wednesday, October 18, 2023 / Notices For Further Information Contact: Carlisha Gentles, PharmD, BCPS, CDCES, Scientific Review Officer, National Center for Injury Prevention and Control, CDC, 4770 Buford Highway NE, Mailstop F–63, Atlanta, Georgia 30341, Telephone: (770)488–1504; Email: CGentles@cdc.gov. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2023–23007 Filed 10–17–23; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–1815–N] Medicare Program; Public Meeting for New Revisions to the Healthcare Common Procedure Coding System (HCPCS) Coding—November 28–30, 2023 Centers for Medicare & Medicaid Services (CMS), Health and Human Services. ACTION: Notice. AGENCY: This notice announces the dates and times of the virtual Healthcare Common Procedure Coding System (HCPCS) public meeting to be held November 28, 2023 through November 30, 2023 to discuss our preliminary coding, Medicare benefit category, and payment determinations for new revisions to the HCPCS Level II code set for non-drug and non-biological products, as well as how to register for those meetings. DATES: Virtual Meeting Dates: Tuesday, November 28, 2023, 9 a.m. to 5 p.m., eastern standard time (EST); Wednesday, November 29, 2023, 9 a.m. to 5 p.m., EST; and Thursday, November 30, 2023, 9 a.m. to 5 p.m., EST. ddrumheller on DSK120RN23PROD with NOTICES1 SUMMARY: Virtual Meeting Location: The HCPCS public meetings will be held virtually via Zoom only. ADDRESSES: VerDate Sep<11>2014 18:01 Oct 17, 2023 Jkt 262001 FOR FURTHER INFORMATION CONTACT: Sundus Ashar, (410) 786–0750, Sundus.ashar1@cms.hhs.gov, or HCPCS@cms.hhs.gov. SUPPLEMENTARY INFORMATION: I. Background On December 21, 2000, Congress enacted the Medicare, Medicaid, and the Children’s Health Insurance Program (CHIP) Benefits Improvement and Protection Act of 2000 (BIPA) (Pub. L. 106–554). Section 531(b) of BIPA mandated that the Secretary establish procedures that permit public consultation for coding and payment determinations for new durable medical equipment (DME) under Medicare Part B of title XVIII of the Social Security Act (the Act). In the November 23, 2001 Federal Register (66 FR 58743), we published a notice providing information regarding the establishment of the annual public meeting process for DME. In 2020, we implemented changes to our HCPCS coding procedures, including the establishment of quarterly coding cycles for drugs and biological products and biannual coding cycles for non-drug and non-biological items and services. In the December 28, 2021 Federal Register (86 FR 73860), we published a final rule that established procedures for making Medicare benefit category and payment determinations for new items and services that are DME, prosthetic devices, orthotics and prosthetics, therapeutic shoes and inserts, surgical dressings, or splints, casts, and other devices used for reductions of fractures and dislocations under Medicare Part B. II. Public Meeting Agendas Prior to registering to attend a virtual public meeting, all potential participants and other stakeholders are advised to review the public meeting agendas at https://www.cms.gov/ Medicare/Coding/MedHCPCSGenInfo/ HCPCSPublicMeetings which identify our preliminary coding, Medicare benefit category, and payment determinations, and the date each item will be discussed. In establishing the public meeting agendas, we may group multiple, related code applications under the same agenda item. III. Virtual Meeting Registration The November 28, 2023 through November 30, 2023 HCPCS public meetings will be virtual and available for remote audio attendance and participation only via Zoom. The registration link will be posted in the Guidelines for Participation in HCPCS Public Meetings document on the CMS PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 website at https://www.cms.gov/ Medicare/Coding/MedHCPCSGenInfo/ HCPCSPublicMeetings and in an announcement on the HCPCS General Information page at https:// www.cms.gov/Medicare/Coding/ MedHCPCSGenInfo. The same website also contains detailed information on how attendees can join the virtual public meetings using Zoom, including dial-in information. All individuals who plan to speak (15 or 5 minutes) at the virtual public meetings must register to attend. All other attendees can access the virtual public meeting through the Zoom link which will be posted on the HCPCS website after the speaker registration closes on Tuesday, November 14, 2023. Attendees can attend more than one day of the public meeting. A. Required Information for Registration The following information must be provided when registering to be a speaker: • Name; • Company name (if applicable); • Email address; • Any special assistance requests (will be considered if the registration is submitted by 5 p.m. EST, Tuesday, November 14, 2023); • Whether the registrant is a primary speaker or a 5-minute speaker for an agenda item; • Agenda item and Application number; • Whether the primary speaker will use a PowerPoint presentation; and • Whether the registrant will participate in a practice Zoom session, to be held on Monday, November 27, 2023. B. Speakers and Attendees 1. Primary Speakers Each applicant that submitted a HCPCS code application that will be discussed at the virtual public meetings is permitted to designate a primary speaker. Fifteen minutes is the total time interval for a primary speaker per agenda item. The deadline for primary speakers to register and submit any supporting PowerPoint presentation is 5 p.m., EST, Tuesday, November 14, 2023. We will accept PowerPoint presentations if those materials are emailed to: HCPCS@cms.hhs.gov by the stated deadline. Due to the timeframe needed for the planning and coordination of the HCPCS virtual public meetings, materials that are not submitted in accordance with this deadline cannot be accommodated. All PowerPoint presentation materials must not exceed 10 slides and should be E:\FR\FM\18OCN1.SGM 18OCN1

Agencies

[Federal Register Volume 88, Number 200 (Wednesday, October 18, 2023)]
[Notices]
[Pages 71867-71868]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-23007]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the 
following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended, and the Determination of the Director, Office of 
Strategic Business Initiatives, Office of the Chief Operating Officer, 
CDC, pursuant to Public Law 92-463. The grant applications and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)--CE24-029, Grants to Support New 
Investigators in Conducting Research Related to Preventing 
Interpersonal Violence Impacting Children and Youth.
    Date: March 19, 2024.
    Time: 8:30 a.m.-5 p.m., EDT.
    Place: Web Conference.
    Agenda: To review and evaluate grant applications.

[[Page 71868]]

    For Further Information Contact: Carlisha Gentles, PharmD, BCPS, 
CDCES, Scientific Review Officer, National Center for Injury Prevention 
and Control, CDC, 4770 Buford Highway NE, Mailstop F-63, Atlanta, 
Georgia 30341, Telephone: (770)488-1504; Email: [email protected].
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-23007 Filed 10-17-23; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.